Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (1-10 of 505) with videos related to

Pageof 51
Sort By:
Postgraduate Medicine|September 1, 1975
Infection control: progress and problems. IntroductionH C Neu
Annals of Internal Medicine|March 15, 1992
New macrolide antibiotics: azithromycin and clarithromycinH C Neu
Bulletin of the New York Academy of Medicine|July 1, 1987
An introduction to controversies in the diagnosis and management of infectious diseasesH C Neu
Bulletin of the New York Academy of Medicine|July 1, 1987
Controversies in infectious diseases: an analysisH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1983
Antibacterial activity of DL 473, a C3-substituted rifamycin derivativeH C Neu
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Clinical perspectives on imipenemH C Neu
Otolaryngologic Clinics of North America|November 1, 1984
Contemporary antibiotic therapy in otolaryngologyH C Neu
Postgraduate Medical Journal|January 1, 1979
Clinical advances in oral antibiotic therapy. Summary and closing remarksH C Neu
Medical Times|October 1, 1970
Update: bacterial resistance to antimicrobial agentsH C Neu
Drugs|January 1, 1993
Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agentsH C Neu
Pageof 51

Showing results (1-10 of 505) with videos related to

Sort By:
Pageof 51
Postgraduate Medicine|September 1, 1975
Infection control: progress and problems. IntroductionH C Neu
Annals of Internal Medicine|March 15, 1992
New macrolide antibiotics: azithromycin and clarithromycinH C Neu
Bulletin of the New York Academy of Medicine|July 1, 1987
An introduction to controversies in the diagnosis and management of infectious diseasesH C Neu
Bulletin of the New York Academy of Medicine|July 1, 1987
Controversies in infectious diseases: an analysisH C Neu
Antimicrobial Agents and Chemotherapy|September 1, 1983
Antibacterial activity of DL 473, a C3-substituted rifamycin derivativeH C Neu
The Journal of Antimicrobial Chemotherapy|December 1, 1983
Clinical perspectives on imipenemH C Neu
Otolaryngologic Clinics of North America|November 1, 1984
Contemporary antibiotic therapy in otolaryngologyH C Neu
Postgraduate Medical Journal|January 1, 1979
Clinical advances in oral antibiotic therapy. Summary and closing remarksH C Neu
Medical Times|October 1, 1970
Update: bacterial resistance to antimicrobial agentsH C Neu
Drugs|January 1, 1993
Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agentsH C Neu
Pageof 51